(Q35987752)

11 August 2017

1 reference

title

Current state of immunotherapy for bladder cancer (English)

1 reference

11 August 2017

1 reference

1

Wassim Kassouf

1 reference

11 August 2017

Ashish M Kamat

2

1 reference

11 August 2017

publication date

1 December 2004

1 reference

Expert Review of Anticancer Therapy

11 August 2017

published in

1 reference

11 August 2017

volume

4

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

1037-1046

1 reference

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1037

Interference of modern antibacterials with bacillus Calmette-Guerin viability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1037

The role of nitric oxide in bacillus Calmette-Guérin mediated anti-tumour effects in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1037

Immunotherapy of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1037

The treated natural history of high risk superficial bladder cancer: 15-year outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1037

Risk of continued intravesical therapy and delayed cystectomy in BCG-refractory superficial bladder cancer: an investigational approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1037

Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1037

Results of a European comparative randomized study comparing oral bropirimine versus intravesical BCG treatment in BCG-naive patients with carcinoma in situ of the urinary bladder. European Bropirimine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1037

10.1586/14737140.4.6.1037

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference